98%
921
2 minutes
20
Motor control (MC) evolves across the human lifespan, improving during childhood and adolescence, stabilizing in early adulthood, and declining in older age. These developmental and degenerative patterns are linked to neural oscillatory activity, which can be assessed via magnetoencephalography (MEG) to gain insights into motor planning, execution, termination, and command initiation. This review systematically examined age-related changes in MC and neural oscillations, centering on movement-related beta desynchronization (MRBD), post-movement beta rebound (PMBR), and movement-related gamma synchrony (MRGS). Following PRISMA guidelines, 17 cross-sectional studies were identified. The findings revealed significant enhancements in motor efficiency from childhood to adolescence, characterized by faster movement speed, shorter movement duration, weaker MRBD, and increased PMBR and MRGS. From adolescence to early adulthood, further improvements in motor performance were noted, accompanied by strengthened MRBD, PMBR, and a slight decline in MRGS. In older adults, motor performance deteriorates, presenting as slower movement and prolonged duration, alongside heightened resting beta power, elevated MRBD, and reduced PMBR. Alterations in MRGS remain insufficiently explored. Overall, MEG proves valuable for capturing neural dynamics underlying the development and decline of motor control across the lifespan. These findings underscore potential avenues for motor rehabilitation and cognitive interventions, particularly in aging populations.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11870221 | PMC |
http://dx.doi.org/10.1016/j.dcn.2025.101529 | DOI Listing |
Comput Methods Biomech Biomed Engin
September 2025
Institute of Radio Physics and Electronics, University of Calcutta, Kolkata, India.
Parkinson's disease (PD) is a neurodegenerative condition that impairs motor functions. Accurate and early diagnosis is essential for enhancing well-being and ensuring effective treatment. This study proposes a deep learning-based approach for PD detection using EEG signals.
View Article and Find Full Text PDFFront Sports Act Living
August 2025
School of Physical Education, Zhejiang Guangsha Vocational and Technical University of Construction, Dongyang, China.
Introduction: This study examined the impacts of different negative pressure cupping therapies (PCT) on pain relief, functional recovery, and inflammatory regulation in delayed onset muscle soreness (DOMS) after high-intensity exercise, with the aim of clarifying the dose-effect relationship.
Methods: In this study, 55 healthy male participants aged 18-25 were selected and divided into 5 groups: the control group (CTR; = 11) and NPCT groups at different levels (-25 kPa, -35 kPa, -45 kPa, and -55 kPa; = 11 in each group). A high-intensity protocol, which included 6 sets of lunges, squats, and squat jumps, was adopted to induce DOMS in the quadriceps femoris.
Neuropsychiatr Dis Treat
September 2025
Department of Radiology, No. 926 Hospital, Joint Logistics Support Force of PLA, Kaiyuan, Yunnan, 661699, People's Republic of China.
Parkinson's disease (PD) represents a progressive neurodegenerative disorder with escalating global burden, with mechanistic studies revealing α-synuclein propagation through gut-brain axis, mitochondrial defects, and neuroinflammatory cascades driven by genetic-environmental interplay. Recent advancements in diagnostic paradigms have successfully combined α-synuclein seed amplification assays with multimodal neuroimaging techniques, achieving an impressive diagnostic accuracy of 92% during the prodromal stages of disease. Phase II trials highlight disease-modifying potential of α-synuclein-targeting immunotherapies (40% reduction in motor decline) and LRRK2 kinase inhibitors showing blood-brain barrier penetration.
View Article and Find Full Text PDFAnn Clin Transl Neurol
September 2025
23andMe, Inc., Sunnyvale, California, USA.
Objective: To examine the associations of LRRK2 p.G2019S, GBA1 p.N409S, polygenic risk scores (PRS), and APOE E4 on PD penetrance, risk, and symptoms.
View Article and Find Full Text PDFAlcohol Clin Exp Res (Hoboken)
September 2025
Neurodevelopmental Laboratory on Addictions and Mental Health, McLean Hospital, Belmont, Massachusetts, USA.
Background: Examining youth before engagement in risky behaviors may help identify neurobiological signatures that prospectively predict susceptibility to initiating and escalating alcohol and other substance use. Given that frontal and medial temporal (e.g.
View Article and Find Full Text PDF